BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20118992)

  • 21. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
    Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
    Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors.
    Hows JM; Passweg JR; Tichelli A; Locasciulli A; Szydlo R; Bacigalupo A; Jacobson N; Ljungman P; Cornish J; Nunn A; Bradley B; Socié G; ;
    Bone Marrow Transplant; 2006 Dec; 38(12):799-805. PubMed ID: 17075568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL; Barnett MJ; Brain MC; Chan KW; Huebsch LB; Klingemann HG; Meharchand J; Reece DE; Rybka WB; Shepherd JD
    Bone Marrow Transplant; 1991 Dec; 8(6):477-87. PubMed ID: 1790428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the outcomes of allogeneic bone marrow transplantation from partially mismatched related donors, matched sibling donors, and matched unrelated donors in Japanese pediatric patients: a single center result.
    Nagatoshi Y; Kawano Y; Okamura J
    Pediatr Transplant; 2004 Jun; 8(3):260-6. PubMed ID: 15176964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
    Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
    Bone Marrow Transplant; 1995 Apr; 15(4):619-25. PubMed ID: 7655390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unmanipulated bone marrow transplantation from one-HLA locus mismatched siblings carries high transplant-related mortality in Chinese patients.
    Leung AY; Lie AK; Au WY; Hawkins BR; Kwong YL; Liang R
    Haematologica; 2001 May; 86(5):518-22. PubMed ID: 11410416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.
    Passweg JR; Pérez WS; Eapen M; Camitta BM; Gluckman E; Hinterberger W; Hows JM; Marsh JC; Pasquini R; Schrezenmeier H; Socié G; Zhang MJ; Bredeson C
    Bone Marrow Transplant; 2006 Apr; 37(7):641-9. PubMed ID: 16489361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
    Kim SY; Lee JW; Lim J; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
    Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
    Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
    Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic Bone Marrow Transplants for Pediatric Severe Aplastic Anemia: Real-world Data comparing Matched Related and Unrelated Donors in a Developing Country. Retrospective study on behalf of the Pediatric Hematopoietic Stem Cell Transplant Working Group of the Brazilian Bone Marrow Transplantation Society (SBTMO) and the Brazil-Seattle Consortium (Gedeco).
    Darrigo LG; Colturato V; de Souza MP; Loth G; Calixto R; Seber A; Zecchin VG; Esteves Daudt L; Tavares RB; Arcuri L; de Macedo AV; Vieira AK; Kuwahara C; Ribeiro L; Fernandes JF; Flowers ME; Pasquini R; Bonfim C
    Pediatr Transplant; 2019 Nov; 23(7):e13552. PubMed ID: 31297928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis.
    Duggan P; Booth K; Chaudhry A; Stewart D; Ruether JD; Glück S; Morris D; Brown CB; Herbut B; Coppes M; Anderson R; Wolff J; Egeler M; Desai S; Turner AR; Larratt L; Gyonyor E; Russell JA;
    Bone Marrow Transplant; 2002 Nov; 30(10):681-6. PubMed ID: 12420207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated donor marrow transplants for severe acquired aplastic anemia.
    Hows J; Szydlo R; Anasetti C; Camitta B; Gajewski J; Gluckman E
    Bone Marrow Transplant; 1992; 10 Suppl 1():102-6. PubMed ID: 1521081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD.
    Wawer A; Laws HJ; Dilloo D; Göbel U; Burdach S
    Klin Padiatr; 2004; 216(3):169-75. PubMed ID: 15175962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.